A little bit of research would answer your question. There are only three CGM companies, Medtronic (who is all but out of the game), Dexcom, and Abbott. Medtronic and Dexcom CGMs cost hundreds of dollars a unit (over $300 I think) so they are priced out of animal health. The Abbott Libre is sold for around $60-$80 so it would be the only other option and that is why some veterinarians use it. The market research PR said 40% of veterinarians surveyed had tried it and you can find a ton of veterinarian articles and published papers on its use "off label".
There is a lot of information out there if you look. Abbott has said they will not support CGM's for animals, they will not sell to veterinarians, and they will deactivate accounts they find using it. They are spending hundreds of millions of dollars trying to win market share in the human market which is more lucrative because there are over 500 million diabetics and they would need buy a CGM every 2 weeks.
If you look at the animal numbers there are only 4 million and they use them 3-5 times a year. So for company like Abbott thats worth hundreds of BILLIONS of dollars i cant imagine its worth putting the time, money and effort into. But for a company like ALRT the chance to make a few hundred million a year is extremely worthwhile. It wouldn't be a drop in the bucket for Abbott revenue but it will make ALRT shareholders rich
News 
Market Data 
Discover 
